NeurAxis, Inc.
NRXSNeurAxis, Inc.
NASDAQ
Healthcare
Biotechnology
$7.21
+0.03(0.4%)
52W $1.60 – $7.62
AI-generated
NeurAxis, Inc.
$81MMkt Cap
$4MRev TTM
-$10MNI TTM
-8.5xP/E TTM
Latest Earnings
10-K
FY FY2025Mar 18, 2026NeurAxis, Inc. (NRXS) reported net sales of $3.6M for FY 2025 ending December 31, 2025, a 32.9% increase from $2.7M in FY 2024, driven by higher volume from insured patients, financial assistance programs, and launch of the RED product. Gross profit reached $3.0M, yielding an 84.2% margin, down slightly from 86.5% due to increased discounts and expired inventory. Operating loss...
What Changed Recently
No significant events in the past 90 days.
Fundamentals
How The Business Makes Money
Revenue by Geography
All Other States32.2%($2M)
CA26.8%($2M)
OH16.1%($1M)
IL7.5%($468.6K)
MA6.7%($419.6K)
WI6%($373.2K)
FL4.7%($293.9K)
Analyst View
Company Profile
CIK0001933567
ISINUS64134X2018
CUSIP64134X201
Phone(812) 689-0791
Address11550 North Meridian Street, Carmel, IN, 46032, US
SEC EDGAR